Anglo-Swedish drugmaker is exploring an alliance with another pharmaceutical group for a partnership on a range of drugs or a whole disease area Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,